FundedIQ
Biotechnology

Satellite Bio: Funding, Investors & Team (Nov 2026)

Satellite Bio specializes in cell therapy, regenerative medicine, synthetic biology, cell biology, and tissue engineering. It focuses on the development and implementation of proprietary, off-the-shelf, implantable satellite organs as living therapeutic solutions that can transform the lives of millions of patients who suffer from serious diseases.

www.satellite.bio LinkedIn Cambridge, United States 11-50 employees
Biopharma Biotechnology Medical
Total raised
$82.5M
Rounds
1
Latest
Undisclosed round
Mar 2022

Satellite Bio has raised $82.5M across 1 funding round on record, the most recent an undisclosed round of $82.5M announced in Mar 2022.

That round is above the $8.9M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Satellite Bio Company Profile and Key Stats

Total funding raised
$82.5M
across 1 round on record
Funding rounds on record
1
Latest funding round
Undisclosed round
$82.5M in Mar 2022
Employees
11-50
reported band
Headquarters
Cambridge, United States

Latest funding round on record: Mar 2022.

Satellite Bio Funding Rounds

Date
Round
Amount
Undisclosed round
$82.5M

Satellite Bio Founders and Leadership Team

Name
Role
Contact
Arnav Chhabra
Founder
Locked

Contact details for the Satellite Bio team: 1 of 1 has an email address on file.

Start 14-day free trial →

Satellite Bio Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,188
$8.9M
30,615
$7.8M

Satellite Bio's latest round of $82.5M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Satellite Bio in Biotechnology and Cambridge

Companies Similar to Satellite Bio

Araceli Biosciences specializes in creating scientific instruments for discovering tissue- and cell-based…

Seed $4.5M

Switchpoint Bio is a biotechnology company that offers immune relevant drug treatments.

Pre-Seed $5.3M

Nanopath Inc. is a company that specializes in molecular diagnostics and allows for fast, high-quality…

Series B $25.0M

Frontier Bio is creating lab-grown human tissues as an ethical replacement for animal studies and is setting…

Undisclosed round $380k

Delix Therapeutics is a neuroscience company focused on harnessing the power of psychoplastogens—novel…

Series C $100M

Rgenta Therapeutics develops a pipeline of oral, small-molecule RNA-targeting medicines with an initial focus…

Series B $41.9M

Zafrens, a pharmaceutical research organization, focuses on designing life sciences solutions for…

Series A $6.0M

Quanta is a biotechnology company uncovering novel cancer therapeutic candidates to target driver oncogenes.…

Series D —

Arctic Therapeutics specializes in finding the genetic origins of common diseases and creating successful…

Undisclosed round $21.5M

100XBIO is creating a cutting-edge platform for analyzing multiple T-cells automatically, aiming to…

Pre-Seed $110k

MEND is a company focused on life sciences, determined to assist individuals in achieving better health…

Undisclosed round $1.5M

Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…

Series B $50.0M

Satellite Bio Funding FAQs

What does Satellite Bio do?

Satellite Bio specializes in cell therapy, regenerative medicine, synthetic biology, cell biology, and tissue engineering. It focuses on the development and implementation of proprietary, off-the-shelf, implantable satellite organs as living therapeutic solutions that can transform the lives of millions of patients who suffer from serious diseases.

How much funding has Satellite Bio raised?

Satellite Bio has raised $82.5M across 1 round on record. The most recent is an undisclosed round of $82.5M announced in Mar 2022.

When did Satellite Bio last raise funding?

Satellite Bio's most recent funding round on record is an undisclosed round of $82.5M, announced in Mar 2022.

Who founded Satellite Bio?

FundedIQ lists Arnav Chhabra (Founder) at Satellite Bio.

Where is Satellite Bio headquartered?

Satellite Bio is based in Cambridge, Massachusetts, United States.

How many employees does Satellite Bio have?

Satellite Bio is in the 11-50 employee band.

How does Satellite Bio's funding compare to other Biotechnology startups?

Satellite Bio's latest round of $82.5M is above the $8.9M median round size for Biotechnology companies on FundedIQ across 4,188 tracked companies over the last two years.

About FundedIQ's Satellite Bio Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Satellite Bio is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.